Robuta

https://www.mayo.edu/research/clinical-trials/cls-20319575

Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab in Refractory Cancer -...

Learn more about services at Mayo Clinic.

in combination safety study enoblituzumab pembrolizumab